Open AccessVirological response and resistance mutations to NS3/4A inhibitors in hepatitis C virus-human immunodeficiency virus coinfection
Author(s) -
Alissa Naqvi,
Valérie Giordanengo,
Brigitte Dunais,
F. De Salvador-Guillouët,
I. Perbost,
J. Durant,
Pascal Puglièse,
A. Joulié,
P. M. Roger,
Éric Rosenthal
Publication year - 2015
Publication title -
world journal of hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.913
H-Index - 55
ISSN - 1948-5182
DOI - 10.4254/wjh.v7.i18.2177
Subject(s) - medicine , boceprevir , telaprevir , pegylated interferon , ribavirin , coinfection , hepatitis c virus , adverse effect , hepatitis c , gastroenterology , virology , cirrhosis , virus
To evaluate virological response to telaprevir or boceprevir in combination with pegylated interferon and ribavirin and resistance mutations to NS3/4A inhibitors in hepatitis C virus-human immunodeficiency virus (HCV-HIV) coinfected patients in a real life setting.